Acrospire Investment Management LLC - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q2 2017$3,000
-96.0%
1,634
-92.8%
0.00%
-95.2%
Q1 2017$75,000
-60.7%
22,670
-52.6%
0.06%
-21.5%
Q4 2016$191,000
+5.5%
47,779
+54.9%
0.08%
-34.2%
Q3 2016$181,000
+2485.7%
30,847
+2328.9%
0.12%
+2300.0%
Q2 2016$7,0001,2700.01%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2017
NameSharesValueWeighting ↓
THOMPSON DAVIS & CO., INC. 16,184$95,0000.17%
Acrospire Investment Management LLC 30,847$181,0000.12%
Spark Investment Management LLC 24,000$141,0000.01%
ACCURATE INVESTMENT SOLUTIONS, INC. 2,000$12,0000.01%
Blume Capital Management, Inc. 2,546$15,0000.01%
BLUESTEIN R H & CO LLC 20,000$118,0000.01%
Virtu KCG Holdings LLC 42,562$250,0000.01%
ARCADIA INVESTMENT MANAGEMENT CORP/MI 1,819$11,0000.00%
Integrated Wealth Management 910$5,0000.00%
Krilogy Financial LLC 800$5,0000.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders